Profil
Julie Allen is currently the Vice President-Clinical Operations at Lexeo Therapeutics, Inc. Prior to her current position, she worked as the Head-Development Operations at Global Blood Therapeutics, Inc. from 2021 to 2023.
Before that, she held the position of Head-Americas Clinical Operations at EMD Serono, Inc. in 2019.
From 2017 to 2019, she served as the Region Head-Site Monitoring & Management at AbbVie, Inc. Ms. Allen obtained her undergraduate degree from the University of Windsor in 1986.
Anciens postes connus de Julie Allen
| Sociétés | Poste | Fin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 02/05/2025 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2023 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/04/2019 |
| ABBVIE INC. | Corporate Officer/Principal | 01/02/2019 |
Formation de Julie Allen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
















